يعرض 1 - 20 نتائج من 1,729 نتيجة بحث عن '"АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ"', وقت الاستعلام: 0.76s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal

    المساهمون: Исследование проводилось без спонсорской поддержки

    المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 16, № 4 (2024); 422-437 ; Трансплантология; Том 16, № 4 (2024); 422-437 ; 2542-0909 ; 2074-0506

    وصف الملف: application/pdf

    Relation: https://www.jtransplantologiya.ru/jour/article/view/936/903; White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet. 2009;373(9677):1808–1817. PMID: 19465236 https://doi.org/10.1016/S01406736(09)60609-7; Gruessner RW, Gruessner AC. The current state of pancreas transplantation. Nat Rev Endocrinol. 2013;9(9):555– 562. PMID: 23897173 https://doi.org/10.1038/nrendo.2013.138; Robertson RP. Medical management of diabetes mellitus: options and limitations. In: Gruessner RW, Gruessner AC. (eds.) Transplantation of the Pancreas. 2 nd ed. Springer, Cham; 2023. p. 55–57. https://doi.org/10.1007/978-3-031-20999-4_4; Dean PG, Kudva YC, Stegall MD. Long-term benefits of pancreas transplantation. Curr Opin Organ Transplant. 2008;13(1):85–90. PMID: 18660712 https://doi.org/10.1097/MOT.0b013e3282f2fd7f; Scheuermann U, Rademacher S, Jahn N, Sucher E, Seehofer D, Sucher R, et al. Impact of pre-transplant dialysis modality on the outcome and healthrelated quality of life of patients after simultaneous pancreas-kidney transplantation. Health Qual Life Outcomes. 2020;18(1):303. PMID: 32912255 https://doi.org/10.1186/s12955-020-01545-3; Jenssen T, Hartmann A, Birkeland KI. Long-term diabetes complications after pancreas transplantation. Curr Opin Organ Transplant. 2017;22(4):382– 388. PMID: 28598888 https://doi.org/10.1097/MOT.0000000000000436; Khubutia M, Pinchuk A, Dmitriev I, Storozhev R. Simultaneous pancreaskidney transplantation with duodenoduodenal anastomosis. Transplant Proc. 2014;46(6):1905–1909. PMID: 25131067 https://doi.org/10.1016/j.transproceed.2014.05.070; Загородникова Н.В., Сторожев Р.В., Анисимов Ю.А., Лазарева К.Е., Дмитриев И.В., Микита О.Ю. и др. Оценка качества жизни пациентов после сочетанной трансплантации почки и поджелудочной железы. Трансплантология. 2017;9(3):236–241. https://doi.org/10.23873/2074-0506-2017-9-3236-241; Das DM, Huskey JL, Harbell JW, Heilman RL, Singer AL, Mathur A, et al. Early technical pancreas failure in Simultaneous Pancreas-Kidney Recipients does not impact renal allograft outcomes. Clin Transplant. 2021;35(1):e14138. PMID: 33131111 https://doi.org/10.1111/ctr.14138; Humar A, Ramcharan T, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DE. Technical failures after pancreas transplants: why grafts fail and the risk factors – a multivariate analysis. Transplantation. 2004;78(8):1188– 1192. PMID: 15502718 https://doi.org/10.1097/01.tp.0000137198.09182.a2; Parajuli S, Muth BL, Astor BC, Redfield RR, Mandelbrot DA, Odorico JS, et al. Delayed kidney graft function in simultaneous pancreas-kidney transplant recipients is associated with early pancreas allograft failure. Am J Transplant. 2020;20(10):2822–2831. PMID: 32306520 https://doi.org/10.1111/ajt.15923; Dholakia S, Mittal S, Quiroga I, Gilbert J, Sharples EJ, Ploeg RJ, et al. Pancreas transplantation: past, pre sent, future. Am J Med. 2016;129(7):667– 673. PMID: 26965300 https://doi.org/10.1016/j.amjmed.2016.02.011; Perez Daga JA, Perez Rodriguez R, Santoyo J. Immediate post-operative complications (I): Post-operative bleeding; vascular origin: Thrombosis pancreatitis. World J Transplant. 2020;10(12):415–421. PMID: 33437674 https://doi.org/10.5500/wjt.v10.i12.415; Khubutia MS, Pinchuk AV, Dmitriev IV, Balkarov AG, Storozhev RV, Anisimov YA. Surgical complications after simultaneous pancreas-kidney transplantation: a single-center experience. Asian J Surg. 2016;39(4):232–237. PMID: 26857852 https://doi.org/10.1016/j.asjsur.2015.11.003; Harriman D, Farney AC, Troppmann C, Stratta RJ. Surgical Complications. In: Gruessner RWG, Gruessner AC. (eds.) Transplantation of the Pancreas. 2nd ed. Springer, Cham; 2023. p. 553–583. https://doi.org/10.1007/9783-031-20999-4_42; Xie W, Kantar R, DiChiacchio L, Scalea JR. Simultaneous Pancreas and Kidney Transplantation. In: Gruessner RWG, Gruessner AC. (eds.) Transplantation of the Pancreas. 2 nd ed. Springer, Cham; 2023. p. 271–283. https://doi.org/10.1007/978-3-031-20999-4_22; Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kid ney transplant. Am J Transplant. 2011;11(11):2279–2296. PMID: 21929642 https://doi.org/10.1111/j.16006143.2011.03754.x; Kinoshita K, Yamanaga S, Kaba A, Tanaka K, Ogata M, Fujii M, et al. Optimizing intraoperative blood pressure to improve outcomes in living donor renal transplantation. Transplant Proc. 2020;52(6):1687–1694. PMID: 32448661 https://doi.org/10.1016/j.transproceed.2020.01.166; Kaufmann KB, Baar W, Sil bach K, Knörlein J, Jänigen B, Kalbhenn J, et al. Modifiable risk fac tors for delayed graft function after deceased donor kidney transplanta tion. Prog Transplant. 2019;29(3):269– 274. PMID: 31167610 https://doi.org/10.1177/1526924819855357; Kawasaki S, Kiyohara C, Karashima Y, Yamaura K. Blood pressure management after reperfusion in livingdonor kidney transplantation. Transplant Proc. 2020;52(10):3009–3016. PMID: 32576473 https://doi.org/10.1016/j.transproceed.2020.04.1820; Gingell-Littlejohn M, Koh H, Aitken E, Shiels PG, Geddes C, Kings more D, et al. Below-target postope rative arterial blood pressure but not central venous pressure is associated with delayed graft function. Transplant Proc. 2013;45(1):46–50. PMID: 23267785 https://doi.org/10.1016/j.transproceed.2012.03.058; Choi JM, Jo JY, Baik JW, Kim S, Kim CS, Jeong SM. Risk factors and outcomes associated with a higher use of inotropes in kidney transplant recipients. Medicine (Baltimore). 2017;96(1):e5820. PMID: 28072739 https://doi.org/10.1097/MD.0000000000005820; Heffron TG, Gadowski G, Buckingham F, Salciunas P, Thistlethwaite JR Jr, Stuart FP. Laser Doppler blood flow measurement as a predictor of viability of renal allografts. Curr Surg. 1990;47(6):431–432. PMID: 2279400; Calixto Fernandes MH, Schric ker T, Magder S, Hatzakorzian R. Perioperative fluid management in kidney transplantation: a black box. Crit Care. 2018;22(1):14 PMID: 29368625 https://doi.org/10.1186/s13054-017-1928-2; Sollinger HW, Odorico JS, Knechtle SJ, D'Alessandro AM, Kalayoglu M, Pirsch JD. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg. 1998;228(3):284– 296. PMID: 9742912 https://doi.org/10.1097/00000658-199809000-00002; Sucher R, Schiemanck T, Hau HM, Laudi S, Stehr S, Sucher E, et al. Influence of intraoperative hemodynamic parameters on outcome in simulta neous pancreas-kidney transplant recipients. J Clin Med. 2022;11(7):1966. PMID: 35407575 https://doi.org/10.3390/jcm11071966; Smudla A, Trimmel D, Szab ó G, Fazakas J. Systolic blood pressure pattern: the tick mark signal of delayed renal graft function. Transplant Proc. 2019;51(4):1226–1230. PMID: 31101202 https://doi.org/10.1016/j.transproceed.2019.03.010; Snoeijs MG, Wiermans B, Chris tiaans MH, van Hooff JP, Timmer - man BE, Schurink GW, et al. Recipient hemodynamics during non-heart-beating donor kidney transplantation are major predictors of primary nonfunction. Am J Transplant. 2007;7(5):1158–1166. PMID: 17331108 https://doi.org/10.1111/j.16006143.2007.01744.x; Cavaleri M, Veroux M, Palermo F, Vasile F, Mineri M, Palumbo J, et al. Perioperative goal-directed therapy during kidney transplantation: an impact evaluation on the major postoperative complications. J Clin Med. 2019;8(1):80. PMID: 30642015 https://doi.org/10.3390/jcm8010080; Campos L, Parada B, Furriel F, Castelo D, Moreira P, Mota A. Do intra operative hemodynamic factors of the recipient influence renal graft func tion? Transplant Proc. 2012;44(6):1800– 1803. PMID: 22841277 https://doi.org/10.1016/j.transproceed.2012.05.042; Aulakh NK, Garg K, Bose A, Aulakh BS, Chahal HS, Aulakh GS. Influence of hemodynamics and intra-operative hydration on biochemical outcome of renal transplant recipients. J Anaesthesiol Clin Pharmacol. 2015;31(2):174– 179. PMID: 25948896 https://doi.org/10.4103/0970-9185.155144; Aref A, Zayan T, Sharma A, Halawa A. Utility of central venous pressure measurement in renal transplantation: is it evidence based? World J Transplant. 2018;8(3):61–67. PMID: 29988941 https://doi.org/10.5500/wjt.v8.i3.61; Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41(7):1774–1781. PMID: 23774337 https://doi.org/10.1097/CCM.0b013e31828a25fd; https://www.jtransplantologiya.ru/jour/article/view/936

  9. 9
    Academic Journal

    المصدر: Meditsinskiy sovet = Medical Council; № 16 (2024); 46-52 ; Медицинский Совет; № 16 (2024); 46-52 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/8611/7559; Miceli G, Basso MG, Rizzo G, Pintus C, Tuttolomondo A. The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies. Int J Mol Sci. 2022;23(23):14914. https://doi.org/10.3390/ijms232314914.; Ambrosini S, Mohammed SA, Costantino S, Paneni F. Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine. Minerva Cardiol Angiol. 2021;69(3):331–345. https://doi.org/10.23736/S2724-5683.20.05326-8.; Grover SP, Mackman N. Tissue factor in atherosclerosis and atherothrombosis. Atherosclerosis. 2020;307:80–86. https://doi.org/10.1016/j.atherosclerosis.2020.06.003.; Saha D, Saha S, Sergeeva EG, Ionova ZI, Gorbach AV. Tissue factor and atherothrombosis. Curr Pharm Des. 2015;21(9):1152–1157. https://doi.org/10.2174/1381612820666141013154946.; Ten Cate H, Guzik TJ, Eikelboom J, Spronk HMH. Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment. Cardiovasc Res. 2021;117(9):2030–2044. https://doi.org/10.1093/cvr/cvaa263.; Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86(8):2839–2843. https://doi.org/10.1073/pnas.86.8.2839.; De Luca C, Colangelo AM, Alberghina L, Papa M. Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System. Front Cell Neurosci. 2018;12:459. https://doi.org/10.3389/fncel.2018.00459.; Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ. Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol. 1993;143(1):76–84. Available at: https://europepmc.org/article/MED/8317556.; Enas EA, Varkey B, Dharmarajan TS, Pare G, Bahl VK. Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. Indian Heart J. 2019;71(2):99–112. https://doi.org/10.1016/j.ihj.2019.03.004.; Romagnuolo R, Marcovina SM, Boffa MB, Koschinsky ML. Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a). J Lipid Res. 2014;55(4):625–634. https://doi.org/10.1194/jlr.M036566.; Pavlatos N, Kalra DK. The Role of Lipoprotein(a) in Peripheral Artery Disease. Biomedicines. 2024;12(6):1229. https://doi.org/10.3390/biomedicines12061229.; Boffa MB. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis. Atherosclerosis. 2022;349:72–81. https://doi.org/10.1016/j.atherosclerosis.2022.04.009.; Amengual J, Barrett TJ. Monocytes and macrophages in atherogenesis. Curr Opin Lipidol. 2019;30(5):401–408. https://doi.org/10.1097/MOL.0000000000000634.; Rosenson RS, Tate A, Chen Q, Grushko O, Damodaran D, Mejia P et al. Lipoprotein(a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease.Circulation.2022;146(Suppl. 1):11904. https://doi.org/10.1161/circ.146.suppl_1.11904.; Кобалава ЖД, Конради АО, Недогода СВ, Шляхто ЕВ, Арутюнов ГП, Баранова ЕИ и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786. https://doi.org/10.15829/1560-4071-2020-3-3786.; Ежов МВ, Кухарчук ВВ, Сергиенко ИВ, Алиева АС, Анциферов МБ, Аншелес АА и др. Нарушения липидного обмена. Клинические рекомендации 2023. Российский кардиологический журнал. 2023;28(5):5471. https://doi.org/10.15829/1560-4071-2023-5471.; Чеботарева НВ, Харионовская ЕА, Бирюкова ЕА, Бернс CА, Вуймо ТА. Сравнение методов тромбодинамики и рутинных тестов гемостаза в оценке гиперкоагуляционного синдрома при хроническом гломерулонефрите. Терапевтический архив. 2024;96(6):565–570. https://doi.org/10.26442/00403660.2024.06.202723.; Borissoff JI, Heeneman S, Kilinç E, Kassák P, Van Oerle R, Winckers K et al. Early atherosclerosis exhibits an enhanced procoagulant state. Circulation. 2010;122(8):821–830. https://doi.org/10.1161/CIRCULATIONAHA.109.907121.; Celi A, Cianchetti S, Dell’Omo G, Pedrinelli R. Angiotensin II, tissue factor and the thrombotic paradox of hypertension. Expert Rev Cardiovasc Ther. 2010;8(12):1723–1729. https://doi.org/10.1586/erc.10.161.; Reganon E, Vila V, Martínez-Sales V, Vaya A, Lago A, Alonso P, Aznar J. Association between inflammation and hemostatic markers in atherothrombotic stroke. Thromb Res. 2003;112(4):217–221. https://doi.org/10.1016/j.thromres.2003.12.008.; Ye F, Garton HJL, Hua Y, Keep RF, Xi G. The Role of Thrombin in Brain Injury After Hemorrhagic and Ischemic Stroke. Transl Stroke Res. 2021;12(3):496–511. https://doi.org/10.1007/s12975-020-00855-4.; Han Z, Liu Q, Li H, Zhang M, You L, Lin Y et al. The role of monocytes in thrombotic diseases: a review. Front Cardiovasc Med. 2023;10:1113827. https://doi.org/10.3389/fcvm.2023.1113827.; Ugovšek S, Rehberger Likozar A, Levstek T, Trebušak Podkrajšek K, Zupan J, Šebeštjen M. Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values. Int J Mol Sci. 2024;25(2):736. https://doi.org/10.3390/ijms25020736.; Hancock MA, Boffa MB, Marcovina SM, Nesheim ME, Koschinsky ML. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. J Biol Chem. 2003;278(26):23260–23269. https://doi.org/10.1074/jbc.M302780200.; Boffa MB, Koschinsky ML. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? J Lipid Res. 2016;57(5):745–757. https://doi.org/10.1194/jlr.R060582.; Risman RA, Belcher HA, Ramanujam RK, Weisel JW, Hudson NE, Tutwiler V. Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen. Biomolecules. 2024;14(2):230. https://doi.org/10.3390/biom14020230.; Tsimikas S. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol. 2017;69(6):692–711. https://doi.org/10.1016/j.jacc.2016.11.042.; Muramatsu Y, Minami Y, Kato A, Katsura A, Sato T, Kakizaki R et al. Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study. Int J Cardiol Heart Vasc. 2019;24:100382. https://doi.org/10.1016/j.ijcha.2019.100382.; Ferretti G, Bacchetti T, Johnston TP, Banach M, Pirro M, Sahebkar A. Lipoprotein(a): A missing culprit in the management of athero-thrombosis? J Cell Physiol. 2018;233(4):2966–2981. https://doi.org/10.1002/jcp.26050.; Nave AH, Lange KS, Leonards CO, Siegerink B, Doehner W, Landmesser U et al. Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis. Atherosclerosis. 2015;242(2):496–503. https://doi.org/10.1016/j.atherosclerosis.2015.08.021.; Shiyovich A, Berman AN, Besser SA, Biery DW, Kaur G, Divakaran S et al. Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry. J Am Heart Assoc. 2024;13(10):e034493. https://doi.org/10.1161/JAHA.123.034493.

  10. 10
  11. 11
    Academic Journal

    المصدر: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 7 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 216-221 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 7 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 216-221 ; 2181-3469

    وصف الملف: application/pdf

  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal

    المصدر: Russian Journal of Transplantology and Artificial Organs; Том 26, № 1 (2024); 36-46 ; Вестник трансплантологии и искусственных органов; Том 26, № 1 (2024); 36-46 ; 2412-6160 ; 1995-1191

    وصف الملف: application/pdf

    Relation: https://journal.transpl.ru/vtio/article/view/1742/1561; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1528; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1529; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1530; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1531; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1532; https://journal.transpl.ru/vtio/article/downloadSuppFile/1742/1533; D’Amico G, Bernardi M, Angeli P. Towards a new definition of decompensated cirrhosis. J Hepatol. 2022; 76 (1): 202–207. doi.org/:10.1016/j.jhep.2021.06.018.; D’Amico G, Perricone G. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter? Curr Hepatology Rep. 2019; 18: 144–156. doi.org/10.1007/s11901-019-00473-1.; De Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022; 76 (4): 959–974. doi.org/10.1016/j.jhep.2021.12.022.; Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP et al. OPTN/SRTR 2020 Annual Data Report: Liver. Am J Transplant. 2022 Mar; 22 Suppl 2: 204–309. doi:10.1111/ajt.16978.; Toniutto P, Zanetto A, Ferrarese A, Burra P. Current challenges and future directions for liver transplantation. Liver Int. 2017; 37 (3): 317–327. doi.org/:10.1111/liv.13255.; Gautier SV, Khomyakov SM. Organ donation and transplantation in the Russian Federation in 2021. 14th Report from the Registry of the Russian Transplant Society. Russian Journal of Transplantology and Artificial Organs. 2022; 24 (3): 8–31. doi.org/10.15825/1995-11912022-3-8-31.; Коробка ВЛ, Пасечников ВД, Коробка РВ, Пак ЕС, Шаповалов АМ. Использование эндоскопического лигирования варикозных узлов в комбинации с неселективными β-блокаторами, или самостоятельно, в профилактике кровотечений у больных с асцитом, включенных в лист ожидания трансплантации печени. Вестник трансплантологии и искусственных органов. 2022; 24 (3): 42–50. doi.org/10.15825/1995-1191-2022-3-42-50.; D’Amico G, Pasta L, Morabito A, D’Amico M, Caltagirone M, Malizia G et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014 May; 39 (10): 1180–1193. doi:10.1111/apt.12721.; Balcar L, Tonon M, Semmler G, Calvino V, Hartl L, Incicco S et al. Baveno Cooperation: an EASL consortium. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event. JHEP Rep. 2022 Jun 3; 4 (8): 100513. doi:10.1016/j.jhepr.2022.100513.; Cárdenas A, Ginès P, Uriz J, Bessa X, Salmerón JM, Mas A et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001 Oct; 34 (4 Pt 1): 671–676. doi:10.1053/jhep.2001.27830. PMID: 11584362.; Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology. 2007 Jan; 45 (1): 223–229. doi:10.1002/hep.21443.; Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006 Nov; 4 (11): 1385–1394. doi:10.1016/j.cgh.2006.08.007.; Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010 May; 51 (5): 1675–1682. doi:10.1002/hep.23500. PMID:20186844.; De Franchis R. Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743–752. doi.org/10.1016/j.jhep.2015.05.022.; Варикозное расширение вен пищевода. Практические рекомендации Всемирной гастроэнтерологической организации. Available at: https://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-russian-2014.pdf.; Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003; 38 (1): 258–266. doi.org/10.1053/jhep.2003.50315.; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. 2012; 2 (Suppl.): 1–138.; Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites [published corrections appears in J Hepatol. 2015; 63: 290. doi.org/10.1016/j.hep.2015.04.001]. J Hepatol. 2015; 62 (4): 968–974. doi.org/10.1016/j.jhep.2014.12.029.; DeMers D, Wachs D. Physiology, Mean Arterial Pressure. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538226/.; Хубутия МШ, Восканян СЭ, Сюткин ВЕ, Чуланов ВП, Новрузбеков МС, Пасечников ВД и др. Рекомендации по профилактике и лечению инфекций вирусами гепатита В и С у больных, находящихся в листе ожидания трансплантации печени, и реципиентов печени. Трансплантология. 2020; 12 (3): 231–244. doi.org/10.23873/2074-0506-2020-12-3-231-244.; Singh V, Kumar P, Verma N, Vijayvergiya R, Singh A, Bhalla A. Propranolol vs. band ligation for primary prophylaxis of variceal hemorrhage in cirrhotic patients with ascites: a randomized controlled trial. Hepatol Int. 2022 Aug; 16 (4): 944–953. doi:10.1007/s12072-02210361-4.; Scheiner B, Parada-Rodriguez D, Bucsics T, Schwabl P, Mandorfer M, Pfisterer N et al. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices. Scand J Gastroenterol. 2017 Sep; 52 (9): 1008–1015. doi:10.1080/00365521.2017.1329456.; Коробка ВЛ, Пасечников ВД, Коробка РВ, Пак ЕС, Шаповалов АМ, Пасечников ДВ, Шитиков ИВ. Сравнение эффективности неселективных бета-блокаторов и эндоскопического лигирования варикозных вен пищевода в первичной профилактике кровотечений у больных с асцитом, включенных в лист ожидания трансплантации печени. Медицинский вестник Северного Кавказа. 2023; 18 (1): 14–20. doi.org/10.14300/mnnc.2023.18004.; Pérez-Ayuso RM, Valderrama S, Espinoza M, Rollán A, Sánchez R, Otarola F et al. Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high-risk esophageal varices. Ann Hepatol. 2010 Jan-Mar; 9 (1): 15–22.; Wei ZG, Wei FX, Shao ZW, Su GH, Qi XP, Zhang YC. Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension. Ther Clin Risk Manag. 2018 Dec 24; 15: 45–57. doi:10.2147/TCRM.S184863.; Pfisterer N, Dexheimer C, Fuchs EM, Bucsics T, Schwabl P, Mandorfer M et al. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther. 2018 Apr; 47 (7): 966–979. doi:10.1111/apt.14485.; Lai M, Fenton C, Ge J, Rubin J, Lai JC, Cullaro G. Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis. Hepatol Commun. 2023 Sep 27; 7 (10): e0255. doi:10.1097/HC9.0000000000000255.; Sersté T, Njimi H, Degré D, Deltenre P, Schreiber J, Lepida A et al. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis. Liver Int. 2015 Aug; 35 (8): 1974–1982. doi:10.1111/liv.12786. Epub 2015 Feb 4. PMID: 25611961.; Ngwa T, Orman E, Gomez EV, Vuppalanchi R, Kubal C, Chalasani N, Ghabril M. Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation. BMC Gastroenterol. 2020 Jan 6; 20 (1): 4. doi:10.1186/s12876-019-1155-1.; https://journal.transpl.ru/vtio/article/view/1742

  15. 15
    Academic Journal
  16. 16
    Academic Journal

    المصدر: The Siberian Journal of Clinical and Experimental Medicine; Том 39, № 1 (2024); 126-134 ; Сибирский журнал клинической и экспериментальной медицины; Том 39, № 1 (2024); 126-134 ; 2713-265X ; 2713-2927

    وصف الملف: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/2193/941; Greenberg E.M., Kaled E.S. Thrombocytopenia. Crit. Care Nurs. Clin. North Am. 2013;25(4):427–434. DOI:10.1016/j.ccell.2013.08.003.; Talargia F., Getacher L. Thrombocytopenia and associated factors among HIV infected patients in pre- and post-anti-retroviral therapy, North East Ethiopia. J. Blood Med. 2021;12:741–748. DOI:10.2147/JBM.S323086.; Belkin M.N., Uriel N. Heart health in the age of highly active antiretroviral therapy: a review of HIV cardiomyopathy. Curr. Opin. Cardiol. 2018;33(3):317–324. DOI:10.1097/HCO.0000000000000513.; Freiberg M.S., Chang C.H., Skanderson M., Patterson O.V., DuVall S.L., Brandt C.A. et al. Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: Results from the veterans aging cohort study. JAMA Cardiol. 2017;2(5):536–546. DOI:10.1001/jamacardio.2017.0264.; Barberato S.H., Romano M.M.D., Beck A.L.S., Rodrigues A.C.T., Almeida A.L.C., Assunção B.M.B.L. et al. Position statement on indications of echocardiography in adults – 2019. Arq. Bras. Cardiol. 2019;113(1):135– 181. DOI:10.5935/abc.20190129.; Durandt C., Potgieter J.C., Mellet J., Herd C., Khoosal R., Nel J.G. et al. HIV and haematopoiesis. S. Afr. Med. J. 2019;109(8b):40–45. DOI:10.7196/SAMJ.2019.v109i8b.13829.; Karki S., Deenadayalan V., Atluri R., Soon-Shiong R. Impact of thrombocytopenia on the outcomes of patients admitted with heart failure: Analysis of the National Inpatient Sample. Circulation. 2023;147:AP585. DOI:10.1161/circ.147.suppl_1.P585.; Nascimento F.G., Tanaka P.Y. Thrombocytopenia in HIV-infected patients. Indian. J. Hematol. Blood Transfus. 2012;28(2):109–111. DOI:10.1007/s12288-011-0124-9.; Kyeyune R., Saathoff E., Ezaamama A.E., Löscher T., Fawzi W., Guwatudde D. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda. BMC Infect. Dis. 2014;14(1):496. DOI:10.1186/1471-2334-14-496.; Alkholifi F.K., Abdi S.A.H., Qadri M. Global prevalence and associated clinical markers of thrombocytopenia in people living with HIV: Evidence from meta-analysis. Clin. Pract. 2022;12(6):867–875. DOI:10.3390/clinpract12060091.; Poulton J., Taylor C.M., De Giovanni J.V. Dilated cardiomyopathy associated with haemolytic uraemic syndrome. Br. Heart J. 1987;57(2):181– 183. DOI:10.1136/hrt.57.2.181.; Hitchcock I.S., Hafer M., Sangkhae V., Tucker J.A. The thrombopoietin receptor: revisiting the master regulator of platelet production. Platelets. 2021;32(6):770–778. DOI:10.1080/09537104.2021.1925102.; Xiao B., Ye J.Y., Xu Y., Yang M. [Molecular mechanism of thrombopoietin signal pathways and its new effects]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013;21(1):254–257. (In Chinese). DOI:10.7534/j.issn.1009-2137.2013.01.052.; Lupia E., Goffi A., Bosco O., Montrucchio G. Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediators Inflamm. 2012;2012:390892. DOI:10.1155/2012/390892.; Simon F., Bergeron D., Larochelle S., Lopez-Vallé C.A., Genest H., Armour A. et al. Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis. Burns. 2012;38(3):421–427. DOI:10.1016/j.burns.2011.09.001.; Fragao-Marcues M., Miranda I., Martins D., Barroso I., Mendes C., Pereira-Neves A. et al. Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis. BMC Cardiovasc. Disord. 2020;20(1):468. DOI:10.1186/s12872-020-01754-0.; de Brouwer P., Bikker F.J., Brand H.S., Kaman W.E. Is TIMP-1 a biomarker for periodontal disease? A systematic review and meta-analysis. J. Periodontal. Res. 2022;57(2):235–245. DOI:10.1111/jre.12957.; Jayashree K., Yasir M., Senthilkumar G.P., Ramesh Babu K., Mehalingam V., Mohanraj P.S. Circulating matrix modulators (MMP-9 and TIMP1) and their association with severity of diabetic retinopathy. Diabetes Metab. Syndr. 2018;12(6):869–873. DOI:10.1016/j.dsx.2018.05.006.; Mäkelä K., Kairisto V., Peltola O., Hollmén T., Virtanen A., Pulkki K. et al. Effect of platelet count on serum and plasma potassium: evaluation using database information from two hospitals. Scand. J. Clin. Lab. Invest. Suppl. 1995;222:95–100. DOI:10.3109/00365519509088455.; Carpenito M., Fanti D., Mega S., Benfari G., Bono M.C., Rossi A. et al. The central role of left atrium in heart failure. Front. Cardiovasc. Med. 2021;8:704762. DOI:10.3389/fcvm.2021.704762.; https://www.sibjcem.ru/jour/article/view/2193

  17. 17
    Academic Journal

    المصدر: Bulletin of Medical Science; Vol. 33 No. 1 (2024): Bulletin of Medical Science; 52-61 ; Бюллетень медицинской науки; Том 33 № 1 (2024): Бюллетень медицинской науки; 52-61 ; 2541-8475

    وصف الملف: application/pdf

  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Report